Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Showing results for

Prof. Sibson together with her co-applicants Prof. Anthony, Dr Campbell and Prof. Middleton have now been awarded a second MRC DPFS grant, for £3.3 million, to acquire further preclinical data to support the case for clinical translation, to develop the mutTNF production for human use and to undertake pre-clinical toxicology.

Histology and magnetic resonance images from a mouse with breast cancer brain metastases, injected intravenously 2 hours previously with a TNFR1-selective mutant TNF protein.

3 items in the picture:

Cresyl violet stained brain section showing location of a micrometastasis.

Adjacent brain section stained with Hanker-Yates demonstrates HRP extravasation (brown staining) and, hence, BBB breakdown selectively at the site of metastasis.

Post-contrast (gadolinium-DTPA) image from the same mouse showing extravasation of contrast at the metastatic site (hyperintensity) confirming local BBB breakdown. Note, the BBB remains intact in the rest of the brain. — Figure caption: Histology and magnetic resonance images from a mouse with breast cancer brain metastases, injected intravenously 2 hours previously with a TNFR1-selective mutant TNF protein. (A) Cresyl violet stained brain section showing location of a micrometastasis (boxed region and inset). (B) Adjacent brain section stained with Hanker-Yates demonstrates HRP extravasation (brown staining) and, hence, BBB breakdown selectively at the site of metastasis. (C) Post-contrast (gadolinium-DTPA) image from the same mouse showing extravasation of contrast at the metastatic site (hyperintensity) confirming local BBB breakdown. Note, the BBB remains intact in the rest of the brain.

Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023).

Perletta V. et al, (2026), ESMO Real World Data Digit Oncol, 12

Mitigating algorithmic unfairness arising from forgetfulness of medical records in clinical artificial intelligence.

Chen Y. et al, (2026), Nat Commun

Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours.

Glasspool R. et al, (2026), Invest New Drugs

The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical care.

Sharma A. et al, (2026), BJU Int, 137, 849 - 857

A preclinical setup for spatially fractionated radiation therapy with electrons.

Taylor ERJF. et al, (2026), Med Phys, 53

Real-time intraoperative depth estimation in transsphenoidal surgery using deep learning: A feasibility study.

Zanier O. et al, (2026), J Clin Neurosci, 147

Population‐Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole‐Genome Sequencing in Japan

Chi S. et al, (2026), Cancer Science

Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia.

Holt-Martyn JP. et al, (2026), RSC Med Chem

Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma.

Zamani SA. et al, (2026), Nat Med

Committee on Medical Aspects of Radiation in the Environment (COMARE) Twentieth report Risks of cardiovascular disease from exposure to ionising radiation

de Vocht F. et al, (2026)

DNA methylation signatures of mismatch repair-deficient colorectal cancer

Ward R. et al, (2026)

Generation of biologically responsive colon-like intestinal tissue patches from human induced pluripotent stem cells using a rapid co-differentiation platform.

Dalleywater W. et al, (2026), Stem Cell Res Ther

Hepatobiliary surgical training in a changing educational landscape: An 18-year longitudinal analysis of a high-volume international fellowship programme.

Wettstein D. et al, (2026), Eur J Surg Oncol, 52

Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome.

Vendramin R. et al, (2026), Immunity

SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell Carcinoma.

Ortmann BM. et al, (2026), Cancer Res

Deep learning-enhanced data-driven gating improves FDG PET/CT clinical image quality.

Wilson Z. et al, (2026), EJNMMI Phys

CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer.

Rajamanickam V. et al, (2026), Transl Oncol, 66

The vital role of p97/valosin-containing protein-mediated degradation pathways in tumour immunity.

Phyu SM. et al, (2026), Curr Opin Cell Biol, 99

Recent advances in synthetic virtual 3D endoscopy to assist in skull base surgery.

Staartjes VE. et al, (2026), Expert Rev Neurother, 26, 371 - 380

Characterisation of bacteria-induced colitis and its modulation by probiotics in naked mole rats: a new mammalian model for acute inflammatory disease.

Hart DW. et al, (2026), J Pathol, 268, 493 - 511

Load More